• A. Deputy Minister for Therapeutic Affairs, Ministry of Health, Riyadh, Saudi Arabia
• Founding president of the Saudi Society of Clinical Pharmacy
• Professor at Al-Faisal University, School of Medicine and Pharmacy
• Editor-in-chief of the Saudi Journal of Clinical Pharmacy
• Fellow of the American College of Chest Physicians, the American Society of Transplantation, the American College of Clinical Pharmacy and of the American Society of Health System Pharmacy
• Holds several consultancy positions at the World Health Organization, Saudi Food and Drug Authority, and the Saudi Commission for Health Specialties
• Published more than 100 original peer-reviewed research papers.

• Consultant Pediatrician specializing in Clinical Genetics and Metabolic Medicine.
• Head of the Division of Genetics and Metabolic Medicine at the Pediatric Department of Prince Sultan Medical Military City.
• Professor of Genetics at Alfaisal University, and holds the position of Head of the Genetic Department at Seha Virtual Hospital, as well as the Head of Genetic Centers in the Ministry of Health.
• Head of the Scientific Committee for the Birth Defect Registry in the Saudi Health Council.
• She has authored over 120 papers and is particularly interested in the Birth Defect Registry and population awareness.
• She has actively participated in numerous awareness campaigns as the Head of the Saudi Society of Medical Genetics.

• Prof. Tomasz Kluszczynski is an international healthcare, life sciences and HEOR expert and a visiting professor at Warsaw and Frankfurt Universities.
• He is also an author or co-author of White Papers and articles on Patient Access, Value Based Agreements and HTA.
• His academic career was at University of Oxford, and he continues to collaborate widely with Universities, Professional and Patient Associations and Ministries of Health in Europe, Middle East and North Africa.
• In the GCC region, Prof. Tomasz has advised on Saudi Arabia’s HTA development and was involved in the design and launch of the UAE Value Based Healthcare System (Ejadah).

• A biotechnologist with more than 10 years of experience in the development of biopharmaceuticals using recombinant-DNA technology, mainly monoclonal antibodies.
• He holds a master and a PhD degree in biotechnology from the Australian Institute for Bioengineering and Nanotechnology, University of Queensland, Australia.
• He was an associate professor in biotechnology at the Faculty of Pharmacy at King Abdulaziz University, and a PI at the Vaccine and Immunotherapy Unit at King Fahd Medical Research.
• He was the director of the Industrial Biomanufacturing Training Program located at King Abdulaziz University, which covers a variety of topics associated with the discovery, development, characterization and production of biologics.
• Published more than 15 peer-reviewed research articles in the field of biotechnology.

• Chairman of Genetics and Precision Medicine department at King Abdulaziz Medical City, Director of Medical Genomic lab at KAIMRC, and Professor of Pediatrics and Genetics at King Saud bin Abdulaziz University for Health Sciences.
• Founder and editor in chief of Journal of Biochemical and Clinical Genetics, Editorial board member of International Journal of Health Sciences, the Journal of Nature and Science of Medicine (JNSM), BMC Medical Genomics and Journal of Pediatric Genetics.
• Author of 3 books and one chapter in a book.
• He has more than 200 publications and more than 200 abstracts.
• He contributed to the discovery of 70 novel genes specifically for disorders involving the brain.
• He discovered a syndrome with dysmorphic features, intellectual disability, and speech delay, which was named Alfadhel syndrome by the OMIM database.
• He received an award on the mobile app he invented for the treatment of inborn errors of metabolism (IEM Drugs).

• Prof. Ramadi is an Assistant Professor of Bioengineering at New York University (NYU), and Director of the Laboratory for Advanced Neuroengineering and Translational Medicine at NYU Abu Dhabi.
• He is also an affiliated Professor of Radiology at NYU Langone Health and Grossman School of Medicine and inaugural co-director of the NYU Abu Dhabi Center for Translational Medical Devices.
• His research focuses on developing non-invasive technologies for neuromodulation, towards more effective therapies for neurological, endocrine, and immune disorders.
• Prior to his faculty appointments, he was a NIH F32 Ruth Kirschstein Postdoctoral fellow at the Massachusetts Institute of Technology (MIT) and Brigham and Women’s Hospital.
• He is a former director of MIT Hacking Medicine, a group dedicated to enhancing healthcare entrepreneurship, and currently is the Regional Director for the MENA region.
• Prof. Ramadi is also a guest instructor at the Harvard T.H. Chan School of Public Health.

• Consultant Geneticist at the Department of Medical Genomics and the Department of Translational Genomics, Center for Genomic Medicine at King Faisal Specialist Hospital & Research Centre (KFSH&RC)
• Professor of Genetics at College of Medicine, Alfaisal University, Riyadh.
• Chairman of the National Committee for Genetic Diseases, Saudi Health Council, the Chairman of the Scientific Committee of the National Newborn Screening, Public Health Authority, and the Program Director of the Clinical Molecular Genetics and Genomics Fellowship Program at KFSH&RC.
• In 2008, Prof. Al-Hassnan co-founded the Cardiovascular Genetics Program at KFSH&RC, which has served thousands of patients and family members with familial cardiac diseases.
• He has participated in numerous national and international workshops and conferences and has published many papers in peer-reviewed international journals.

• Dr. Summar is well-known for his pioneering work in caring for children diagnosed with rare diseases.
• He founded and led the Rare Disease Institute at Children’s National in Washington D.C.
• He has developed new drugs for sickle cell anemia, congenital heart disease, and neonatal lung disease.
• He is the past-board chairman of the National Organization for Rare Disorders where he helped establish the Clinical Centers of Excellence Program and IAMRARE natural history program.
• He also developed the international rare disease clinical treatment protocols program, RareCap
• He has organized and is a part of a number of international work groups and has numerous board positions.
• He is a recipient of NORD’s Lifetime Achievement Award for his work in rare disease.

• President of Asia Pacific Alliance of Rare Disease Organizations, Treasurer of UN NGO for Rare Diseases, Chair of Patient Advocates Constituency Committee of International Rare Disease Research Consortium, and on the Editorial Boards of The Patient Centred Outcomes Research and Rare Diseases and Orphan Drugs Journal.
• President & CEO of the Canadian Organization for Rare Disorders, the Institute for Optimizing Health Outcomes and Canadian Heart Patient Alliance.
• She serves on Canada’s Rare Disease Drug Strategy Implementation Advisory Group, Canada’s Rare Disease Network Steering Committee and Canada’s Newborn Screening Advisory Group.
• She has a PhD in psychology from McGill University and was professor at the University of Windsor, Canada.
• She is a certified Health Coach and author of three books and many articles.

• Managing Director of the Biotechnology Park at KAIMRC/MNGHA.
• Distinguished Visiting Scholar at Boston Children’s Hospital.
• Founding Vice President for Research, Executive Director for Biomedical Research Institute and Chairman at National Research Fund at Qatar Foundation.
• Dr. Haoudi served as Research Professor of cancer and infectious diseases, a fellow of the US National Institutes of Health, Visiting Professor at Harvard Medical School (USA) and a fellow at Institut Pasteur (France).
• Dr. Haoudi was elected as a member of the Royal Academy for Science and Technology and graduated from University Paris Sorbonne, with a Ph.D. in cellular and molecular genetics and received executive education from Harvard Business School in Corporate Management and Strategy.
• Founder and Editor-In-Chief for the Journal Biomed Research International and is a member of the International scientific advisory board for the Lancet Oncology.

• Critical Respiratory Care Program Director at Jazan Health Cluster.
• Chairman of the Scientific Committee for Critical Respiratory Care Diploma at the Saudi Council for Health Specialties.
• Founding member for the first Respiratory Care Unit at Ministry of Health.
• Board Member of the Saudi Society for Respiratory Care.
• Bachelor Degree of Respiratory Care University of Toledo, United States of America.
• Master Degree of Health Science- Respiratory Therapy, Georgia State University, United States of America.